Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

  1. Thieblemont, C.
  2. Howlett, S.
  3. Casasnovas, R.-O.
  4. Mounier, N.
  5. Perrot, A.
  6. Morschhauser, F.
  7. Fruchart, C.
  8. Daguindau, N.
  9. van Eygen, K.
  10. Obéric, L.
  11. Bouabdallah, R.
  12. Pica, G.M.
  13. Nicolas-Virezelier, E.
  14. Abraham, J.
  15. Fitoussi, O.
  16. Snauwaert, S.
  17. Eisenmann, J.-C.
  18. Lionne-Huyghe, P.
  19. Bron, D.
  20. Tricot, S.
  21. Deeren, D.
  22. Gonzalez, H.
  23. Costello, R.
  24. Le Du, K.
  25. da Silva, M.G.
  26. Grosicki, S.
  27. Trotman, J.
  28. Catalano, J.
  29. Caballero, D.
  30. Greil, R.
  31. Cohen, A.M.
  32. Gaulard, P.
  33. Roulin, L.
  34. Takeshita, K.
  35. Casadebaig, M.-L.
  36. Tilly, H.
  37. Coiffier, B.
  38. Erakutsi egile guztiak +
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Argitalpen urtea: 2020

Alea: 189

Zenbakia: 1

Orrialdeak: 84-96

Mota: Artikulua

DOI: 10.1111/BJH.16300 GOOGLE SCHOLAR lock_openSarbide irekia editor